# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
RBC Capital analyst Ben Hendrix reiterates AdaptHealth (NASDAQ:AHCO) with a Outperform and maintains $13 price target.
AdaptHealth (NASDAQ:AHCO) reported quarterly earnings of $0.13 per share which missed the analyst consensus estimate of $0.16 b...
Wolf has served on AdaptHealth's Board since November 2019 and will assume the role from outgoing Chairman Richard Barasch....
Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and maintains $13 price target.
AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.05 b...
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-center...